Showing results (51-60 of 222) with videos related to
Sort By:
Pageof 23
Human Molecular Genetics|November 16, 2013
Functional microRNAs and target sites are created by lineage-specific transpositionRyan M Spengler, Clayton K Oakley, Beverly L DavidsonMolecular Therapy. Nucleic Acids|May 1, 2013
Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain StructureJames C Geoghegan, Brian L Gilmore, Beverly L DavidsonCell Metabolism|March 12, 2024
Fndc5 is translated from an upstream ATG start codon and cleaved to produce irisin myokine precursor protein in humans and miceNathan H Witmer, Connor R Linzer, Ryan L BoudreauNature Biotechnology|September 24, 2002
siRNA-mediated gene silencing in vitro and in vivoHaibin Xia, Qinwen Mao, Henry L Paulson, et al.FEBS Letters|April 23, 2003
Membrane topology of CLN3, the protein underlying Batten diseaseQinwen Mao, Brian J Foster, Haibin Xia, et al.Journal of Medicinal Chemistry|April 18, 2003
Tripeptide probes for tripeptidyl protease I production via gene transferMeeKyoung Kim, Qinwen Mao, Beverly L Davidson, et al.Trends in Neurosciences|July 5, 2011
Clarifying lysosomal storage diseasesMark L Schultz, Luis Tecedor, Michael Chang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 8, 2023
Targeted long-read sequencing captures CRISPR editing and AAV integration outcomes in brainBryan P Simpson, Carolyn M Yrigollen, Aleksandar Izda, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2012
Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage diseaseYong Hong Chen, Kristin Claflin, James C Geoghegan, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 11, 2005
Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystoniaPedro Gonzalez-Alegre, Nicole Bode, Beverly L Davidson, et al.Pageof 23